As frustration mounts in places such as Germany with what is perceived as a slow and inefficient vaccine rollout, calls […]
The U.S. Department of Health and Human Services today announced plans to allocate initial doses of Regeneron’s investigational monoclonal antibody […]
The monoclonal antibody cocktail developed by Regeneron and made well-known by POTUS during his stay at Walter Reed Medical Center […]
Regeneron’s monoclonal antibody investigational product known as REGN-COV2 has been touted by trial site’s all over the United States, almost […]
Regeneron Pharmaceuticals, Inc. announced October 28th, 2020 positive, prospective results from an ongoing Phase 2/3 seamless trial in the COVID-19 […]
Regeneron and Sanofi announced positive results from the phase 3 LIBERTY ASTHMA VOYAGE trial which evaluated Dupixent (dupilumab) in children aged […]
Regeneron reported that subsequent to the New York-based company’s discussions with regulatory authorities, they have submitted a request to the […]
Much attention has gone to Regeneron and the monoclonal antibody cocktail known as REGN-CoV2, especially given the investigational drug was […]
TrialSite has reported that Lilly’s monoclonal antibody (LY-CoV555) evidenced promise at a trial site location in southern Texas and that […]
The prominent global RECOVERY (Randomized Evaluation of COVid-19 thERapY) is one of the world’s largest randomized clinical trials of potential […]
